• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Astounding Norwegian research breakthrough with Rituximab can solve CFS mystery!!!

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
http://www.newscientist.com/article/dn21065-chronic-fatigue-syndrome-eased-by-cancer-drug.html

http://www.tv2.no/nyheter/innenriks...reakthrough-can-solve-cfsmystery-3615631.html

Full paper is here:

http://www.plosone.org/article/info:doi/10.1371/journal.pone.0026358

In conclusion, we have shown that B-lymphocyte depletion with the monoclonal anti-CD20 antibody Rituximab, two infusions two weeks apart, is associated with significant, though generally transient clinical responses, with CFS symptom improvement in two thirds of the included patients. No major toxicity was observed in 12 months follow-up. Even though this study is small, it is a randomised, double-blind, and placebo-controlled study showing significant differences in favour of the Rituximab group, and with general improvement of all CFS symptoms. Thus, we believe that B-cell depletion targets a central player in the pathogenesis of the CFS disease, directly or indirectly. Whether this mechanism applies to specific subsets of CFS patients or the group as a whole is a subject for further research. While this study can be interpreted as preliminary, being the first to describe the treatment principle in CFS except for our pilot case series [4], we believe the results are best compatible with an autoimmune disease mechanism and that the presented findings may have a major impact on the direction of biomedical research in CFS. Based on new pilot patient experiences, we have now started two new open-label phase-II studies investigating Rituximab treatment with two infusions two weeks apart (as in the present study) followed by maintenance Rituximab infusions at 3, 6, 10 and 15 months, to further explore this treatment principle in CFS (ClinicalTrials.gov, NCT01156909 and NCT01156922). The present study may be interpreted as a proof of principle. The next studies will indicate to what extent the patients actually over time may recover through B-cell depletion treatment.
 

currer

Senior Member
Messages
1,409
Yep, I was there when they presented their findings at the IiME Conference back in May.

Well done to everyone for not leaking it out. Its been a LONG wait.
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
I'm just reveling in the fact that the earllest news coverage out, right on the spot of when the embargo lifted, was in the NEW SCIENTIST.

World-class, some say world's leading, science publication....and it's BRITISH.

Dying to see what the rest of the UK media makes of this. Where are the quotes from Weasel?? We must hear them ASAP!
 

currer

Senior Member
Messages
1,409
I have to admit that I always feared the rituximab findings would be used to re-cast ME as an auto-immune disease and distract from a retroviral hypothesis.

The type of B cells that are killed by rituximab (CD20) are the same ones that Judy Mikovits said contained the retrovirus.

In fact I remember her coming up to talk directly after Dr Mella and as she came to the stage she said that she was not surprised by their findings as the virus was in the CD20 B cells.

She praised their study. (That bit is not on the DVD)

At the conference the norwegians said they had failed to find XMRV but they also said they could not identify the expected autoantibodies either.

(I will now read the paper to see if they have found them yet.)

In the published paper the authors are open to a viral etiology in the form of a B-lymphotropic virus.

However they prefer an autoimmune hypothesis.

So the cause is as yet unknown.
 

jstefl

Senior Member
Messages
250
Location
Brookfield, Wisconsin
The part of the video I liked best was the part where the presenter looked at the camera and emphatically said that the patients that he saw were really sick, and that CFS was a real illness. It was clearly aimed at the mental health crowd.

So, what now? Do we all go for it? The presenter mentioned that they had filed for a patent on the treatment. What does that mean? Does that mean that all other doctors are prohibited from using that treatment? It doesn't seem right that a group that made an accidental discovery should own the right to treat patients.

I am sending a copy of the paper to my doctor. I seriously doubt if he will give me the rituximab, but I see it as worth a shot anyway.

John
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
Rituximab costs a damn fortune, BTW. I doubt many of us would be able to pay for it out of pocket, even if a doctor would prescribe chemo drugs on spec, which I suspect 99.99% of them would not, as well they shouldn't. This is early work, and the studies are continuing - unfortunately, for now, only in Norway.

Sorry I haven't been following past threads on this - how does this result compare to the best possible results seen for Ampligen?
 

jstefl

Senior Member
Messages
250
Location
Brookfield, Wisconsin
Currer:

The video presentation clearly left open the possibility of a viral, or retroviral, trigger for the illness. Their auto immune idea was presented as their opinion, not a proven fact.

John
 

urbantravels

disjecta membra
Messages
1,333
Location
Los Angeles, CA
European ME Alliance statement:

http://www.euro-me.org/news-Q42011-002.htm

The European ME Alliance welcomes the research by Fluge, Mella et al published on 19th October 2011 in Plos One.

This research clearly shows the physical basis of ME.

It also shows that patients had no difficulty in adjusting to normal life - something which makes redundant the previous attributions to psychological problems in this patient group.

Now we encourage public funding bodies in different countries to follow the example of this double blind placebo controlled clinical trial to start seriously investing in biomedical research into ME.

It is time to take this disease seriously and help patients regain their health and normal functioning.

European ME Alliance
 

currer

Senior Member
Messages
1,409
Yes, John, I remember they were quite fair about the cause, leaving it open.

They were so excited, too. I spoke to Dr Mella afterwards. Wow, what a day!
 

currer

Senior Member
Messages
1,409
We should all get a copy of this paper and KEEP IT ON US AT ALL TIMES for use in a tight spot.

It is OUR PASSPORT TO HUMAN RIGHTS.

It should stop the psyches dead in their tracks.

I intend to give it to my doctor. (No chance he'd watch the DVD)
 

jstefl

Senior Member
Messages
250
Location
Brookfield, Wisconsin
Just out of curiosity, how much does it cost?

I don't know if the paper mentioned it, but the video mentioned that there is a new three year study underway using multiple injections over a period of 15 months. This paper is based on two injections given two weeks apart.

John
 

Deatheye

Senior Member
Messages
161
Nice. But you know what bugs me? The Answer autoimmun disease. Thats basically another word for we don't know. There so many autoimmun diseases out there and still new stuff appears to be cause by autoimmun diseases. And noone knows whats causing this. Personally I don't see autoimmun disease as a real answer.
Its kinda like saying the bulllet caused the death of a person its not murderer and not trying to find out who pulled the trigger. Giving everyon bullet proof equipment and not worrying about all the people running around shooting.
 

busybee

Senior Member
Messages
119
Personally... I don't care what caused it, how many people know why they have a disease? I want effective treatment so I can get my life back.
 

perrier

Senior Member
Messages
1,254
rheumatoid arthritis?

BusyBee included a link just now which indicates Rituximab has been used not only for cancer but for arthritis too.

Most distressing in the interview is the statement that it will be years before a treatment is available. Millions around the world are unable to work due to this illness. The cost to individuals and society is incalculable, not to mention that lives are destroyed in their prime.
I have to believe that somehow this is going to be available sooner than in 'years.' What can we do?
 

busybee

Senior Member
Messages
119
BusyBee included a link just now which indicates Rituximab has been used not only for cancer but for arthritis too.

Most distressing in the interview is the statement that it will be years before a treatment is available. Millions around the world are unable to work due to this illness. The cost to individuals and society is incalculable, not to mention that lives are destroyed in their prime.
I have to believe that somehow this is going to be available sooner than in 'years.' What can we do?

Hi Helene
I was suprised by the rheumatoid arthritis link.

Dr Shepard suggests trials in the UK, so we find someone to do trials.